An FDA advisory committee voted unanimously in favour of a booster dose of Johnson & Johnson's one-shot COVID-19 vaccine on Friday, as panellists suggested it should have been used as a
NICE has delivered its first verdict on NHS funding of Janssen's oral multiple sclerosis drug Ponvory, and it's not good news for patients with the disease waiting for new treatment options
Janssen UK & Ireland’s managing director Gaëtan Leblay discusses the importance of maintaining the spotlight on our mental health post-pandemic, and why we must hone our mental resilien
Johnson & Johnson's COVID-19 vaccine has been a minor player in the US vaccination drive so far, but the company hopes it can have a bigger role as a booster shot.